Young
Investigator Symposium : Group A @
8:30-12:05 |
| YIS-A
Session I |
8:30-10:10
k100l |
| Chairs:
Keiko Sakai & Kazuhiko Maeda |
8:30-8:50
y20z |
O-3A-18 |
Takushi
Nomura
NIID, Japan
|
Broadening of
CD8+ T-cell targets precedes accumulation of proviral escape mutations
in SIV controllers |
8:50-9:10
y20z |
O-3A-19 |
Hayato
Murakoshi
Kumamoto University, Japan
|
Effective control
of HIV-1 by cytotoxic T cells specific for multiple conserved epitopes
|
9:10-9:30
y20z |
O-3A-20 |
Macdonald
Mahiti
Kumamoto University, Japan |
Natural isolated
HIV-1 Nef differentially recognize the cytoplasmic tails of HLA-A
and HLA-B molecules for down-regulation |
9:30-9:50
y20z |
O-3A-21 |
Takayuki
Chikata
Kumamoto University, Japan
|
The impact of
amino-acid substitution at a position outside the peptide binding
groove of HLA-C subtypes in HIV-1-specific T cell recognition |
| 9:50-10:10 y20z |
O-3A-22 |
Zhansong
Lin
Kumamoto University, Japan |
The effect of
co-expression of KIRs and their HLA ligands on HIV-1 control |
| 10:10-10:25k15l@ |
Coffee
Break |
| YIS-A
Session II |
10:25-12:05
k100l |
| Chairs:
Takeo Kuwata & Hayato Murakoshi |
| 10:25-10:45
y20z |
O-3A-23 |
Keiko
Sakai
Kumamoto University, Japan
|
Investigation
of the association of Gag-dependent replication capacities with clinical
outcomes of HIV-1 infection. |
| 10:45-11:05
y20z |
O-3A-24 |
Muntasir
Alam
Kumamoto University, Japan
|
Mutations in
gp41 that confer resistance to fusion inhibitors enhance the neutralization
sensitivity to antibodies against both gp41 and gp120 |
11:05-11:25
y20z |
O-3A-25 |
Kristel
Ramirez
Kumamoto University, Japan
|
Evaluation of
complementarity and synergy of conventional anti-HIV-1 antibodies
derived from a single individual |
11:25-11:45
y20z |
O-3A-26 |
Hesham
E. Nasser
Kumamoto University, Japan
|
Phenotypic characterization
of fibrocytes, the recently identified HIV-1 host cells |
| 11:45-12:05 y20z |
O-3A-27 |
Michihiro
Hashimoto
Kumamoto University, Japan
|
Nef-induced activation
of macrophages is mediated by TAK1 and macropinocytosis |
| Young
Investigator Symposium : Group B@
8:30-12:05 |
| YIS-B
Session I |
8:30-10:10
k100l |
| Chairs:
Shigeyoshi Harada & Takeshi Nishijima |
8:30-8:50
y20z |
O-3B-28 |
Daisuke
Mizushima
NCGM / Kumamoto University, Japan
|
Prognosis of
renal function of Vietnamese HIV-infected patients with mild-to-moderate
renal dysfunction on tenofovir |
8:50-9:10
y20z |
O-3B-29 |
Samatchaya
Boonchawalit
Kumamoto University / NIID, Japan
|
Impact of maraviroc
(MVC)-resistant mutations in the C1 and C4 regions of gp120 on sensitivity
to antibody-mediated neutralization |
9:10-9:30
y20z |
O-3B-30 |
Hironori
Hayashi
NCGM, Japan
|
Dimerization
of HIV-1 Protease Occurs through Two Steps, Which Relates to the Mechanism
of Protease Dimerization Inhibition by Darunavir |
9:30-9:50
y20z |
O-3B-31 |
Yorifumi
Satou
Kumamoto University, Japan
|
HIV-1 integration
site analysis by using next generation sequencing: a tool to study
HIV-1 reservoir cells |
| 9:50-10:10 y20z |
O-3B-32 |
Yasuaki
Yanagawa
NCGM / Kumamoto University, Japan |
Long-term Prognosis
for HIV Associated Kaposifs Sarcoma In the Era of cART in Japan |
| 10:10-10:25k15l@ |
Coffee
Break |
| YIS-B
Session II |
10:25-12:05
k100l |
|
Chairs: Kazuaki Monde & Ryota Koba |
10:25-10:45
y20z |
O-3B-33 |
Ekram
W. Abd El- Wahab
Alexandria Univ., Egypt / Kumamoto Univ., Japan
|
Specific Recognition
of the HIV-1 genomic RNA by the Gag precursor |
10:45-11:05
y20z |
O-3B-34 |
Sarah
Ameen Almofty
Kumamoto University, Japan
|
A TREX-2 component
GANP is dispersed from the nuclear envelope during HIV-1 virus entry
and associated with integrase in the host cell nucleus |
11:05-11:25
y20z |
O-3B-35 |
Mayuko
Shimoda
Kumamoto University, Japan
|
GANP that interacts with HIV-1 integrase inherently
suppresses retrotransposition |
11:25-11:45
y20z |
O-3B-36 |
Kazuaki
Monde
Kumamoto University, Japan
|
Intrinsic interference between human endogenous retrovirus
and HIV-1. |
| 11:45-12:05 y20z |
O-3B-37 |
Shigeyoshi
Harada
NIID, Japan |
Genetic and Structure-Function
Analyses of Human Immunodeficiency Virus Type 1 Escape from CD4 Mimic
Small Compounds (CD4MCs) |